Why the study?
Evidence shows little benefit of PCI in ischemic cardiomyopathy, potentially due to heterogeneity, prompting characterization of ICM phenotypes using latent class analysis.
Does clinical phenotyping using latent class analysis predict differences in mortality and heart failure hospitalization in patients with ischemic cardiomyopathy undergoing PCI?
Does clinical phenotyping using latent class analysis predict differences in mortality and heart failure hospitalization in patients with ischemic cardiomyopathy undergoing PCI?
Patients with ischemic cardiomyopathy undergoing PCI exhibit distinct clinical phenotypes that are associated with significantly different risks of mortality, heart failure hospitalization, and responses to left ventricular reverse remodeling.
Answers are grounded in this paper and cite their sources.
Supports phenotyping for post-PCI prognosis in ischemic cardiomyopathy; hypothesis-generating and requires prospective validation.
BACKGROUND: Percutaneous coronary intervention (PCI) is a good option for patients with ischemic cardiomyopathy (ICM) at high operative risk. However, evidence shows little benefit of PCI, potentially due to heterogeneity in ICM. Here, we applied latent class analysis (LCA) to clinical data to characterize ICM phenotypes based on clinical features and to assess differences in clinical outcomes. METHODS AND RESULTS: LCA was performed on data from 492 patients with a left ventricular (LV) ejection fraction <50% who underwent PCI. Primary outcomes included all-cause mortality and heart failure (HF) hospitalization. The optimal number of clinical phenotypes was 3. Phenotype 1 (n=101) was characterized by severe chronic kidney disease and a high frequency of hemodialysis. Phenotype 2 (n=192) included men with early-onset ICM, a high frequency of lifestyle-related diseases, and a high body mass index. Phenotype 3 (n=199) included older adults with a high prevalence of atrial fibrillation, moderate/severe mitral regurgitation, and high B-type natriuretic peptide levels. The risk of combined all-cause mortality and HF hospitalization was significantly lower for Phenotype 2 than the other phenotypes. LV reverse remodeling (LVRR) was associated with a lower incidence of the primary outcome in Phenotype 3, but not in the other phenotypes. CONCLUSIONS: We identified differences in clinical outcomes and LVRR across clinical ICM phenotypes after PCI, suggesting distinct underlying mechanisms across ICM phenotypes that may benefit from targeted treatments.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: